{
    "topic": "us_house",
    "source": "The Hill",
    "bias": 1,
    "url": "https://thehill.com/homenews/house/447210-liberals-rip-democratic-leaders-for-writing-drug-pricing-bill-in-secret",
    "title": "Liberals rip Democratic leaders for writing drug pricing bill in secret",
    "date": "2019-06-06",
    "authors": "",
    "content": "Progressive House Democrats are growing increasingly frustrated with their party \u2019 s leadership , accusing them of writing Democrats \u2019 signature bill to lower prescription drug prices in secret and without their input .\nRep. Lloyd Doggett Lloyd Alton DoggettWhite House talking new tax cuts with GOP On The Money : Lawmakers hammer Zuckerberg over Facebook controversies | GOP chair expects another funding stopgap | Senate rejects Dem measure on SALT deduction cap workarounds House committee advances measure taxing nicotine in vaping products MORE ( D-Texas ) compared the process around Speaker Nancy Pelosi Nancy PelosiOvernight Health Care : Trump officials making changes to drug pricing proposal | House panel advances flavored e-cig ban | Senators press FDA tobacco chief on vaping ban Speaker Pelosi , it 's time to throw American innovators a lifeline Why Americans must tune in to the Trump impeachment hearings MORE \u2019 s ( D-Calif. ) drug pricing measure to the secrecy surrounding the GOP \u2019 s ObamaCare repeal bill in 2017 , when Sen. Rand Paul Randal ( Rand ) Howard PaulSenate GOP waves Trump off early motion to dismiss impeachment charges McConnell discounts quick dismissal of Trump impeachment articles : 'We 'll have to have a trial ' GOP motions to subpoena whistleblower MORE ( R-Ky. ) famously wheeled a photocopier across the Capitol in a dramatized search for the hidden legislation .\nRep. Mark Pocan Mark William PocanGOP senator rips into Pelosi at Trump rally : 'It must suck to be that dumb ' House progressives to push for floor amendments on Pelosi drug price bill How Trump and Pelosi went from bad to worse MORE ( D-Wis. ) , co-chairman of the Congressional Progressive Caucus , likened Pelosi \u2019 s plan to the Loch Ness monster , saying it has been just as elusive .\nAt issue is a plan Pelosi \u2019 s office has been working on for months that would allow Medicare to negotiate drug prices , a top priority for Democrats and one that the party stressed in its campaign last year to win back the House .\nThere is now an intense debate within the Democratic caucus over the details of that proposal , with the Progressive Caucus pushing for a bill authored by Doggett that it says is stronger because it would strip a company of its monopoly on a drug if the manufacturer refuses to agree to a reasonable price in Medicare negotiations .\nPelosi \u2019 s office is working on a different mechanism , one that progressives worry is too weak . Her approach would empower an outside third party to set the price of a drug if Medicare and the drug company could not come to an agreement .\nProgressive lawmakers argue they can not properly weigh in on Pelosi \u2019 s plan because they have not seen anything on paper . After months of rumors , Pelosi presented an outline of the plan two weeks ago in a private meeting that included Pocan , but did not provide a hard copy of the proposal .\nAsked on Tuesday if he thought leadership \u2019 s process had been open enough , Pocan told reporters , \u201c There has been no process up to now . \u201d\nThat same day , Doggett told reporters , \u201c We have a great history with Republicans where they locked up their health care plan so that even Rand Paul couldn \u2019 t see it , and they held their tax plan to the last minute , so if there is to be good collaboration here there needs to be more openness . \u201d\nPocan , Doggett and other progressives say they have come up empty in their attempts to get more details from leadership .\nDemocratic leaders will likely need progressives to help pass a drug pricing bill if it eventually comes to the floor , but liberal lawmakers say they can \u2019 t pledge support for legislative text they haven \u2019 t seen .\nWhen asked about the complaints from progressives , Henry Connelly , a Pelosi spokesman , said party leaders are still in the process of gathering input from members .\n\u201c Leadership and the committees of jurisdiction continue to solicit feedback and incorporate ideas from across the caucus in order to develop the strongest , boldest possible legislation to lower prescription drug prices for all Americans , \u201d Connelly said .\nRep. Alexandria Ocasio-Cortez Alexandria Ocasio-CortezSanders says Ocasio-Cortez will play a 'very important role ' in his administration if he 's elected Top Sanders adviser suggests polling underestimates campaign support Omar renews claim Stephen Miller is a 'white nationalist ' amid calls for him to step down MORE ( D-N.Y. ) , a champion for progressives , told reporters on Wednesday it \u2019 s a problem that \u201c most members , \u201d including her , do not know the details of Pelosi \u2019 s drug pricing plan .\n\u201c That \u2019 s a problem and it \u2019 s part of a pattern , I think , where we don \u2019 t know things until 48 hours before . And then it \u2019 s like , \u2018 You \u2019 re either with us or you \u2019 re against us , \u2019 \u201d Ocasio-Cortez said .\nIn a sign of their frustration , both Doggett and Pocan showed up at a meeting organized by House Democratic Caucus Chairman Hakeem Jeffries Hakeem Sekou JeffriesHouse Democrat 's Halloween display mourns passed bills that die in McConnell 's 'legislative graveyard ' Democrats unveil impeachment procedures Top Trump administration officials hail al-Baghdadi raid but stress need for resolve in fighting ISIS MORE ( N.Y. ) on Tuesday that was intended to help get newer Democratic lawmakers up to speed on drug pricing . The two veteran lawmakers later expressed frustration to reporters after no new details of leadership \u2019 s plan were revealed at the briefing .\nPocan said he delivered a warning in the meeting that leadership should not try to move a drug pricing bill in the next week or two without waiting to get input from progressives .\nHouse Majority Leader Steny Hoyer Steny Hamilton Hoyer Hoyer calls GOP efforts to out whistleblower 'despicable ' Live coverage : House holds first public impeachment hearing Congress hunts for path out of spending stalemate MORE ( D-Md . ) told reporters on Tuesday that the chamber is occupied with appropriations for June , but that \u201c we \u2019 ll see whether by July we \u2019 re ready to deal with prescription drugs . \u201d\nAdding to progressives \u2019 concerns is the fact that Pelosi \u2019 s staff has been in talks with White House staffers for months on drug pricing . Progressives are worried that Pelosi will water down her plan in an effort to secure a rare bipartisan deal with President Trump Donald John TrumpGOP senators balk at lengthy impeachment trial Warren goes local in race to build 2020 movement 2020 Democrats make play for veterans ' votes MORE .\nThe Speaker \u2019 s office has emphasized that the House will move forward on drug pricing no matter what ends up happening with the administration talks .\nThe parts of Pelosi \u2019 s plan outlined so far have drawn concerns from progressives .\nPocan called it \u201c horrendous \u201d that her proposal would not require Medicare to negotiate prices for all drugs , but instead set a minimum of 25 drugs per year where prices had to be negotiated . He added that there are some good parts to the plan , namely that the mandated lower prices would apply to people with private insurance plans , not just Medicare .\nHouse Energy and Commerce Committee Chairman Frank Pallone Jr. Frank Joseph PalloneOvernight Health Care : Trump officials making changes to drug pricing proposal | House panel advances flavored e-cig ban | Senators press FDA tobacco chief on vaping ban House panel advances flavored e-cigarette ban Lawmakers call for extra security for anti-Erdo\u011fan protesters MORE ( D-N.J. ) and House Ways and Means Committee Chairman Richard Neal Richard Edmund NealJudge sides with NY officials in Trump tax return lawsuit On The Money : US paid record .1B in tariffs in September | Dems ramp up oversight of 'opportunity zones ' | Judge hints at letting House lawsuit over Trump tax returns proceed Judge hints at letting House lawsuit over Trump tax returns proceed MORE ( D-Mass . ) have been on a \u201c listening tour \u201d this year , meeting with groups of House Democrats across the ideological spectrum on drug prices .\nBut some lawmakers say those meetings have been nothing more than general discussions of different options , without providing details of Pelosi \u2019 s plan .\n\u201c We are going to talk to the Speaker and make it clear that we really need to see the proposal , \u201d said Rep. Pramila Jayapal Pramila JayapalProgressive House Democrat unveils bill to allow state-based 'Medicare for All ' Progressives press Democrats to rethink Israel policy Democratic lawmakers call on Judiciary Committee to advance 'revenge porn ' law MORE ( D-Wash. ) , noting that she discussed the issue with other Progressive Caucus leaders on Wednesday morning .\nOn the other side of the caucus , Rep. Kurt Schrader Walter ( Kurt ) Kurt SchraderCaution for Democrats : Voters care more about drug pricing than impeaching Trump Here are the House Democrats who are n't backing Trump impeachment inquiry Centrist Democrats fret over impeachment gamble MORE ( Ore. ) , a member of the moderate Blue Dog Democrats who helps lead the group \u2019 s work on health care issues , said , \u201c No , not really , \u201d when asked if he knew the details of Pelosi \u2019 s proposal .\n\u201c It \u2019 s one of three or so different alternatives that \u2019 s out there , \u201d Schrader said . \u201c It \u2019 s probably going to end up as the preferred alternative , because she \u2019 s the Speaker . \u201d",
    "content_original": "Progressive House Democrats are growing increasingly frustrated with their party\u2019s leadership, accusing them of writing Democrats\u2019 signature bill to lower prescription drug prices in secret and without their input.\n\nRep. Lloyd Doggett Lloyd Alton DoggettWhite House talking new tax cuts with GOP On The Money: Lawmakers hammer Zuckerberg over Facebook controversies | GOP chair expects another funding stopgap | Senate rejects Dem measure on SALT deduction cap workarounds House committee advances measure taxing nicotine in vaping products MORE (D-Texas) compared the process around Speaker Nancy Pelosi Nancy PelosiOvernight Health Care: Trump officials making changes to drug pricing proposal | House panel advances flavored e-cig ban | Senators press FDA tobacco chief on vaping ban Speaker Pelosi, it's time to throw American innovators a lifeline Why Americans must tune in to the Trump impeachment hearings MORE\u2019s (D-Calif.) drug pricing measure to the secrecy surrounding the GOP\u2019s ObamaCare repeal bill in 2017, when Sen. Rand Paul Randal (Rand) Howard PaulSenate GOP waves Trump off early motion to dismiss impeachment charges McConnell discounts quick dismissal of Trump impeachment articles: 'We'll have to have a trial' GOP motions to subpoena whistleblower MORE (R-Ky.) famously wheeled a photocopier across the Capitol in a dramatized search for the hidden legislation.\n\nADVERTISEMENT\n\nRep. Mark Pocan Mark William PocanGOP senator rips into Pelosi at Trump rally: 'It must suck to be that dumb' House progressives to push for floor amendments on Pelosi drug price bill How Trump and Pelosi went from bad to worse MORE (D-Wis.), co-chairman of the Congressional Progressive Caucus, likened Pelosi\u2019s plan to the Loch Ness monster, saying it has been just as elusive.\n\nAt issue is a plan Pelosi\u2019s office has been working on for months that would allow Medicare to negotiate drug prices, a top priority for Democrats and one that the party stressed in its campaign last year to win back the House.\n\nThere is now an intense debate within the Democratic caucus over the details of that proposal, with the Progressive Caucus pushing for a bill authored by Doggett that it says is stronger because it would strip a company of its monopoly on a drug if the manufacturer refuses to agree to a reasonable price in Medicare negotiations.\n\nPelosi\u2019s office is working on a different mechanism, one that progressives worry is too weak. Her approach would empower an outside third party to set the price of a drug if Medicare and the drug company could not come to an agreement.\n\nProgressive lawmakers argue they cannot properly weigh in on Pelosi\u2019s plan because they have not seen anything on paper. After months of rumors, Pelosi presented an outline of the plan two weeks ago in a private meeting that included Pocan, but did not provide a hard copy of the proposal.\n\nAsked on Tuesday if he thought leadership\u2019s process had been open enough, Pocan told reporters, \u201cThere has been no process up to now.\u201d\n\nThat same day, Doggett told reporters, \u201cWe have a great history with Republicans where they locked up their health care plan so that even Rand Paul couldn\u2019t see it, and they held their tax plan to the last minute, so if there is to be good collaboration here there needs to be more openness.\u201d\n\nPocan, Doggett and other progressives say they have come up empty in their attempts to get more details from leadership.\n\nDemocratic leaders will likely need progressives to help pass a drug pricing bill if it eventually comes to the floor, but liberal lawmakers say they can\u2019t pledge support for legislative text they haven\u2019t seen.\n\nWhen asked about the complaints from progressives, Henry Connelly, a Pelosi spokesman, said party leaders are still in the process of gathering input from members.\n\nADVERTISEMENT\n\n\u201cLeadership and the committees of jurisdiction continue to solicit feedback and incorporate ideas from across the caucus in order to develop the strongest, boldest possible legislation to lower prescription drug prices for all Americans,\u201d Connelly said.\n\nRep. Alexandria Ocasio-Cortez Alexandria Ocasio-CortezSanders says Ocasio-Cortez will play a 'very important role' in his administration if he's elected Top Sanders adviser suggests polling underestimates campaign support Omar renews claim Stephen Miller is a 'white nationalist' amid calls for him to step down MORE (D-N.Y.), a champion for progressives, told reporters on Wednesday it\u2019s a problem that \u201cmost members,\u201d including her, do not know the details of Pelosi\u2019s drug pricing plan.\n\n\u201cThat\u2019s a problem and it\u2019s part of a pattern, I think, where we don\u2019t know things until 48 hours before. And then it\u2019s like, \u2018You\u2019re either with us or you\u2019re against us,\u2019 \u201d Ocasio-Cortez said.\n\nIn a sign of their frustration, both Doggett and Pocan showed up at a meeting organized by House Democratic Caucus Chairman Hakeem Jeffries Hakeem Sekou JeffriesHouse Democrat's Halloween display mourns passed bills that die in McConnell's 'legislative graveyard' Democrats unveil impeachment procedures Top Trump administration officials hail al-Baghdadi raid but stress need for resolve in fighting ISIS MORE (N.Y.) on Tuesday that was intended to help get newer Democratic lawmakers up to speed on drug pricing. The two veteran lawmakers later expressed frustration to reporters after no new details of leadership\u2019s plan were revealed at the briefing.\n\nPocan said he delivered a warning in the meeting that leadership should not try to move a drug pricing bill in the next week or two without waiting to get input from progressives.\n\nHouse Majority Leader Steny Hoyer Steny Hamilton Hoyer Hoyer calls GOP efforts to out whistleblower 'despicable' Live coverage: House holds first public impeachment hearing Congress hunts for path out of spending stalemate MORE (D-Md.) told reporters on Tuesday that the chamber is occupied with appropriations for June, but that \u201cwe\u2019ll see whether by July we\u2019re ready to deal with prescription drugs.\u201d\n\nAdding to progressives\u2019 concerns is the fact that Pelosi\u2019s staff has been in talks with White House staffers for months on drug pricing. Progressives are worried that Pelosi will water down her plan in an effort to secure a rare bipartisan deal with President Trump Donald John TrumpGOP senators balk at lengthy impeachment trial Warren goes local in race to build 2020 movement 2020 Democrats make play for veterans' votes MORE.\n\nThe Speaker\u2019s office has emphasized that the House will move forward on drug pricing no matter what ends up happening with the administration talks.\n\nThe parts of Pelosi\u2019s plan outlined so far have drawn concerns from progressives.\n\nPocan called it \u201chorrendous\u201d that her proposal would not require Medicare to negotiate prices for all drugs, but instead set a minimum of 25 drugs per year where prices had to be negotiated. He added that there are some good parts to the plan, namely that the mandated lower prices would apply to people with private insurance plans, not just Medicare.\n\nHouse Energy and Commerce Committee Chairman Frank Pallone Jr. Frank Joseph PalloneOvernight Health Care: Trump officials making changes to drug pricing proposal | House panel advances flavored e-cig ban | Senators press FDA tobacco chief on vaping ban House panel advances flavored e-cigarette ban Lawmakers call for extra security for anti-Erdo\u011fan protesters MORE (D-N.J.) and House Ways and Means Committee Chairman Richard Neal Richard Edmund NealJudge sides with NY officials in Trump tax return lawsuit On The Money: US paid record .1B in tariffs in September | Dems ramp up oversight of 'opportunity zones' | Judge hints at letting House lawsuit over Trump tax returns proceed Judge hints at letting House lawsuit over Trump tax returns proceed MORE (D-Mass.) have been on a \u201clistening tour\u201d this year, meeting with groups of House Democrats across the ideological spectrum on drug prices.\n\nBut some lawmakers say those meetings have been nothing more than general discussions of different options, without providing details of Pelosi\u2019s plan.\n\n\u201cWe are going to talk to the Speaker and make it clear that we really need to see the proposal,\u201d said Rep. Pramila Jayapal Pramila JayapalProgressive House Democrat unveils bill to allow state-based 'Medicare for All' Progressives press Democrats to rethink Israel policy Democratic lawmakers call on Judiciary Committee to advance 'revenge porn' law MORE (D-Wash.), noting that she discussed the issue with other Progressive Caucus leaders on Wednesday morning.\n\nOn the other side of the caucus, Rep. Kurt Schrader Walter (Kurt) Kurt SchraderCaution for Democrats: Voters care more about drug pricing than impeaching Trump Here are the House Democrats who aren't backing Trump impeachment inquiry Centrist Democrats fret over impeachment gamble MORE (Ore.), a member of the moderate Blue Dog Democrats who helps lead the group\u2019s work on health care issues, said, \u201cNo, not really,\u201d when asked if he knew the details of Pelosi\u2019s proposal.\n\n\u201cIt\u2019s one of three or so different alternatives that\u2019s out there,\u201d Schrader said. \u201cIt\u2019s probably going to end up as the preferred alternative, because she\u2019s the Speaker.\u201d",
    "source_url": "www.thehill.com",
    "bias_text": "center",
    "ID": "ZWRdbVRXODjUGVdA"
}